The FDA is doubling down on its goal to increase biosimilar drug availability in the U.S. with a fresh draft guidance proposing more changes to streamline development of the cheaper biologic copies.
China has approved the world's first commercial brain-computer interface. AstraZeneca is building new cell therapy centers in Shanghai. Astellas ended a T-cell engager pact with CytomX Therapeutics.
This is the primary documentation for the MoveIt project. We strongly encourage you to help improve MoveIt's documentation. Please consider helping improve the tutorials, port old ones from ROS 1, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results